Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study

Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study

Sepsis and sepsis-related multiple organ failure are major causes of mortality in intensive care unit (ICU) settings. This study aimed to determine the effect of intravenous immunoglobulin G (IVIgG) on different types of immunoglobulin and anti-coagulant factor types in sepsis patients. A single-cen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kobe journal of the medical sciences 2020, Vol.66 (1), p.E32-E39
Hauptverfasser: Ando, Yukihiro, Inoue, Shigeaki, Kawashima, Takahisa, Okashiro, Masahiro, Kotani, Joji, Nishiyama, Takashi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E39
container_issue 1
container_start_page E32
container_title Kobe journal of the medical sciences
container_volume 66
creator Ando, Yukihiro
Inoue, Shigeaki
Kawashima, Takahisa
Okashiro, Masahiro
Kotani, Joji
Nishiyama, Takashi
description Sepsis and sepsis-related multiple organ failure are major causes of mortality in intensive care unit (ICU) settings. This study aimed to determine the effect of intravenous immunoglobulin G (IVIgG) on different types of immunoglobulin and anti-coagulant factor types in sepsis patients. A single-center observational study of patients with sepsis, severe sepsis, or septic shock was conducted from August 2008 to March 2013. Patients were divided into the IVIgG (immunoglobulin G [IgG]
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7447101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2435758509</sourcerecordid><originalsourceid>FETCH-LOGICAL-j270t-cbdfa10a2cd72ee8cb1ac576dcc41eb31c4a7bee8307c0d36bd5b3c7f81a115a3</originalsourceid><addsrcrecordid>eNpVkM9q3DAQh01paTZp30HHHmqQLGvl9FAIS7I1bEhg27MZS7NeBVly9WfJvlMfMgrNJZcZhh_zzfB9qFas63hN2-vuY7WitOF1Ixi_qC5jfCrjupXsc3XBm461UohV9a93KcAJnc-R9POcnZ-sH7M1jmzJvdfZQsJI0hHJ7fMSMEbjHfEHssclmlj3TmeFmmw8TNn6BdLxTO5AJR8iAadJ71RAiIWxx5Bn0k_3ZIcntPEHuSGPwccFVTIn_E72xk0W6w26hKEsllo-S68H9ynr85fq0wFsxK9v_ar6c3f7e_Or3j1s-83Nrn5qJE21GvUBGIVGadkgdmpkoIRca6VahiNnqgU5loBTqajm61GLkSt56BgwJoBfVT__c5c8zqgVvjqywxLMDOE8eDDD-8SZ4zD50yDb4peyAvj2Bgj-b8aYhtlEhdaCwyJ6aFoupOgEveYv4fCK1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435758509</pqid></control><display><type>article</type><title>Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study</title><source>Freely Accessible Japanese Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ando, Yukihiro ; Inoue, Shigeaki ; Kawashima, Takahisa ; Okashiro, Masahiro ; Kotani, Joji ; Nishiyama, Takashi</creator><creatorcontrib>Ando, Yukihiro ; Inoue, Shigeaki ; Kawashima, Takahisa ; Okashiro, Masahiro ; Kotani, Joji ; Nishiyama, Takashi</creatorcontrib><description>Sepsis and sepsis-related multiple organ failure are major causes of mortality in intensive care unit (ICU) settings. This study aimed to determine the effect of intravenous immunoglobulin G (IVIgG) on different types of immunoglobulin and anti-coagulant factor types in sepsis patients. A single-center observational study of patients with sepsis, severe sepsis, or septic shock was conducted from August 2008 to March 2013. Patients were divided into the IVIgG (immunoglobulin G [IgG] &lt;870 mg/dL; lower normal range) and non-IVIgG (IgG ≥870 mg/dL) groups. The IVIgG group received IVIgG for three days, and other standard medications. Serial measurements were taken of serum IgG, immunoglobulin A (IgA), immunoglobulin M (IgM), total plasminogen activator inhibitor 1 (tPAI-1), and protein C. Patients in the IVIgG treatment group had significantly higher serum IgM level on Days 4 and 7 than on Day 1, but no significant changes in IgM levels were observed in patients in the non-IVIgG group. Patients in the IVIgG treatment had lower tPAI-1 levels on Days 4 and 7 than on Day 1 and increased protein C levels on Day 7 compared to those on Days 1 and 4. There were no significant differences in tPAI-1 levels or protein C levels in the non-IVIgG group, although a similar trend was observed. IVIgG administration increased patients’ serum IgM and protein C levels and decreased their serum tPAI-1 levels. IVIgG has potential application for preventing sepsis-induced coagulopathy and disseminated intravascular coagulation.</description><identifier>ISSN: 0023-2513</identifier><identifier>EISSN: 1883-0498</identifier><identifier>PMID: 32814755</identifier><language>eng</language><publisher>Kobe University School Of Medicine</publisher><ispartof>Kobe journal of the medical sciences, 2020, Vol.66 (1), p.E32-E39</ispartof><rights>Copyright © 2020 by Kobe Journal of Medical Sciences 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447101/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447101/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,53766,53768</link.rule.ids></links><search><creatorcontrib>Ando, Yukihiro</creatorcontrib><creatorcontrib>Inoue, Shigeaki</creatorcontrib><creatorcontrib>Kawashima, Takahisa</creatorcontrib><creatorcontrib>Okashiro, Masahiro</creatorcontrib><creatorcontrib>Kotani, Joji</creatorcontrib><creatorcontrib>Nishiyama, Takashi</creatorcontrib><title>Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study</title><title>Kobe journal of the medical sciences</title><description>Sepsis and sepsis-related multiple organ failure are major causes of mortality in intensive care unit (ICU) settings. This study aimed to determine the effect of intravenous immunoglobulin G (IVIgG) on different types of immunoglobulin and anti-coagulant factor types in sepsis patients. A single-center observational study of patients with sepsis, severe sepsis, or septic shock was conducted from August 2008 to March 2013. Patients were divided into the IVIgG (immunoglobulin G [IgG] &lt;870 mg/dL; lower normal range) and non-IVIgG (IgG ≥870 mg/dL) groups. The IVIgG group received IVIgG for three days, and other standard medications. Serial measurements were taken of serum IgG, immunoglobulin A (IgA), immunoglobulin M (IgM), total plasminogen activator inhibitor 1 (tPAI-1), and protein C. Patients in the IVIgG treatment group had significantly higher serum IgM level on Days 4 and 7 than on Day 1, but no significant changes in IgM levels were observed in patients in the non-IVIgG group. Patients in the IVIgG treatment had lower tPAI-1 levels on Days 4 and 7 than on Day 1 and increased protein C levels on Day 7 compared to those on Days 1 and 4. There were no significant differences in tPAI-1 levels or protein C levels in the non-IVIgG group, although a similar trend was observed. IVIgG administration increased patients’ serum IgM and protein C levels and decreased their serum tPAI-1 levels. IVIgG has potential application for preventing sepsis-induced coagulopathy and disseminated intravascular coagulation.</description><issn>0023-2513</issn><issn>1883-0498</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkM9q3DAQh01paTZp30HHHmqQLGvl9FAIS7I1bEhg27MZS7NeBVly9WfJvlMfMgrNJZcZhh_zzfB9qFas63hN2-vuY7WitOF1Ixi_qC5jfCrjupXsc3XBm461UohV9a93KcAJnc-R9POcnZ-sH7M1jmzJvdfZQsJI0hHJ7fMSMEbjHfEHssclmlj3TmeFmmw8TNn6BdLxTO5AJR8iAadJ71RAiIWxx5Bn0k_3ZIcntPEHuSGPwccFVTIn_E72xk0W6w26hKEsllo-S68H9ynr85fq0wFsxK9v_ar6c3f7e_Or3j1s-83Nrn5qJE21GvUBGIVGadkgdmpkoIRca6VahiNnqgU5loBTqajm61GLkSt56BgwJoBfVT__c5c8zqgVvjqywxLMDOE8eDDD-8SZ4zD50yDb4peyAvj2Bgj-b8aYhtlEhdaCwyJ6aFoupOgEveYv4fCK1w</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Ando, Yukihiro</creator><creator>Inoue, Shigeaki</creator><creator>Kawashima, Takahisa</creator><creator>Okashiro, Masahiro</creator><creator>Kotani, Joji</creator><creator>Nishiyama, Takashi</creator><general>Kobe University School Of Medicine</general><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2020</creationdate><title>Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study</title><author>Ando, Yukihiro ; Inoue, Shigeaki ; Kawashima, Takahisa ; Okashiro, Masahiro ; Kotani, Joji ; Nishiyama, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j270t-cbdfa10a2cd72ee8cb1ac576dcc41eb31c4a7bee8307c0d36bd5b3c7f81a115a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ando, Yukihiro</creatorcontrib><creatorcontrib>Inoue, Shigeaki</creatorcontrib><creatorcontrib>Kawashima, Takahisa</creatorcontrib><creatorcontrib>Okashiro, Masahiro</creatorcontrib><creatorcontrib>Kotani, Joji</creatorcontrib><creatorcontrib>Nishiyama, Takashi</creatorcontrib><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Kobe journal of the medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ando, Yukihiro</au><au>Inoue, Shigeaki</au><au>Kawashima, Takahisa</au><au>Okashiro, Masahiro</au><au>Kotani, Joji</au><au>Nishiyama, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study</atitle><jtitle>Kobe journal of the medical sciences</jtitle><date>2020</date><risdate>2020</risdate><volume>66</volume><issue>1</issue><spage>E32</spage><epage>E39</epage><pages>E32-E39</pages><issn>0023-2513</issn><eissn>1883-0498</eissn><abstract>Sepsis and sepsis-related multiple organ failure are major causes of mortality in intensive care unit (ICU) settings. This study aimed to determine the effect of intravenous immunoglobulin G (IVIgG) on different types of immunoglobulin and anti-coagulant factor types in sepsis patients. A single-center observational study of patients with sepsis, severe sepsis, or septic shock was conducted from August 2008 to March 2013. Patients were divided into the IVIgG (immunoglobulin G [IgG] &lt;870 mg/dL; lower normal range) and non-IVIgG (IgG ≥870 mg/dL) groups. The IVIgG group received IVIgG for three days, and other standard medications. Serial measurements were taken of serum IgG, immunoglobulin A (IgA), immunoglobulin M (IgM), total plasminogen activator inhibitor 1 (tPAI-1), and protein C. Patients in the IVIgG treatment group had significantly higher serum IgM level on Days 4 and 7 than on Day 1, but no significant changes in IgM levels were observed in patients in the non-IVIgG group. Patients in the IVIgG treatment had lower tPAI-1 levels on Days 4 and 7 than on Day 1 and increased protein C levels on Day 7 compared to those on Days 1 and 4. There were no significant differences in tPAI-1 levels or protein C levels in the non-IVIgG group, although a similar trend was observed. IVIgG administration increased patients’ serum IgM and protein C levels and decreased their serum tPAI-1 levels. IVIgG has potential application for preventing sepsis-induced coagulopathy and disseminated intravascular coagulation.</abstract><pub>Kobe University School Of Medicine</pub><pmid>32814755</pmid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0023-2513
ispartof Kobe journal of the medical sciences, 2020, Vol.66 (1), p.E32-E39
issn 0023-2513
1883-0498
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7447101
source Freely Accessible Japanese Titles; EZB-FREE-00999 freely available EZB journals; PubMed Central
title Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A13%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20Immunoglobulin%20G%20Modulates%20the%20Expression%20of%20Sepsis-Induced%20Coagulopathy%20Factors%20and%20Increases%20Serum%20IgM%20Levels:%20A%20Prospective,%20Single-Center%20Intervention%20Study&rft.jtitle=Kobe%20journal%20of%20the%20medical%20sciences&rft.au=Ando,%20Yukihiro&rft.date=2020&rft.volume=66&rft.issue=1&rft.spage=E32&rft.epage=E39&rft.pages=E32-E39&rft.issn=0023-2513&rft.eissn=1883-0498&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2435758509%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435758509&rft_id=info:pmid/32814755&rfr_iscdi=true